LD-2 disclosure · 2nd Quarter - Report
BIOMERIEUX, INC.
Client
- Name
- BIOMERIEUX, INC.
- Description
- Global in vitro diagnostics company.
- Location
- Utah · United States of America
Registrant
- Description
- Law Firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
6 issuesBudget/Appropriations
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
LobbyistsMARK RAYDER · MICHAEL PARK · JONATHAN JAGODA · ALEXANDER GRAF
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
LobbyistsMARK RAYDER · MICHAEL PARK · ms JOYCE E GRESKO · JAMES PATRICK PALUSKIEWICZ · JONATHAN JAGODA · ALEXANDER GRAF
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.